Berria, R., Gastaldelli, A., Lucidi, S., Belfort, R., De Filippis, E., Easton, C., et al. (2006) Reduction in Hematocrit Level after Pioglitazone Treatment Is Correlated with Decreased Plasma Free Testosterone Level, Not Hemodilution, in Women with Polycystic Ovary Syndrome. Clinical Pharmacology & Therapeutics, 80, 105-114.
https://doi.org/10.1016/j.clpt.2006.03.014

has been cited by the following article:

• TITLE: Peripheral Hematological Parameters in Sudanese Women with Polycystic Ovary Syndrome

  AUTHORS: Shaza Mohammed, Enaam T. Elhaj, Mohamed A. Ahmed, Reem Eltayeb, Ishag Adam

  KEYWORDS: Hemoglobin, Platelets Volume, Polycystic Ovarian Syndrome, Red Blood Cells, White Blood Cells

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.11 No.7, July 15, 2022

  ABSTRACT: The aim of this study is to assess the association between polycystic ovarian syndrome (PCOS) and hematological parameters [hemoglobin, red cell parameters, white blood cells (WBCs), platelets volume (MPV)]. This is a matched case-control study (60 women in each arm of the study) which was conducted in Saad Abualila infertility center Hospital in Khartoum, Sudan. Infertile women with PCOS were the cases and healthy non pregnant women were the controls. The gynecological characteristics were gathered through questionnaire and blood samples were analyzed for different blood parameters by automated hematology analyzer. While the two groups were matched in their age; body mass index was significantly higher in women with PCOs compared to the normal control. The investigated different hematological parameters (hemoglobin, RBCs, RDW, WBCs, platelets and MPV) showed no statistical difference between the women with PCOS and the controls.